loadpatents
Patent applications and USPTO patent grants for FUCEK; Ivica.The latest application filed is for "tandem diabody for cd16a-directed nk-cell engagement".
Patent | Date |
---|---|
Tandem Diabody for CD16A-directed NK-cell Engagement App 20220041717 - ROSS; Thorsten ;   et al. | 2022-02-10 |
Tandem diabody for CD16A-directed NK-cell engagement Grant 11,180,558 - Ross , et al. November 23, 2 | 2021-11-23 |
Uses Of Nk Cell Engaging Antibody Fusion Constructs For Treatments App 20210253698 - Tesar; Michael ;   et al. | 2021-08-19 |
NK cell engaging antibody fusion constructs Grant 11,001,633 - Tesar , et al. May 11, 2 | 2021-05-11 |
Bispecific CD33 and CD3 Binding Proteins App 20210024654 - Ellwanger; Kristina ;   et al. | 2021-01-28 |
Bispecific Egfr/cd16 Antigen-binding Protein App 20200405833 - Kluge; Michael ;   et al. | 2020-12-31 |
Bispecific CD33 and CD3 binding proteins Grant 10,626,190 - Ellwanger , et al. | 2020-04-21 |
Nk Cell Engaging Antibody Fusion Constructs App 20200109202 - Tesar; Michael ;   et al. | 2020-04-09 |
Tandem Diabody for CD16A-directed NK-cell Engagement App 20190345249 - Ross; Thorsten ;   et al. | 2019-11-14 |
Antibody binding sites specific for EGFRvIII Grant 10,273,309 - Ellwanger , et al. | 2019-04-30 |
Multivalent Fv Antibodies App 20190040155 - ELLWANGER; Kristina ;   et al. | 2019-02-07 |
Bispecific CD33 and CD3 Binding Proteins App 20180291113 - ELLWANGER; Kristina ;   et al. | 2018-10-11 |
CD3 binding domains Grant 10,066,015 - Zhukovsky , et al. September 4, 2 | 2018-09-04 |
Bispecific CD33 and CD3 binding proteins Grant 9,803,029 - Ellwanger , et al. October 31, 2 | 2017-10-31 |
Bispecific CD33 and CD3 Binding Proteins App 20160194409 - ELLWANGER; Kristina ;   et al. | 2016-07-07 |
ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII App 20160152728 - ELLWANGER; Kristina ;   et al. | 2016-06-02 |
Cd3 Binding Domains App 20160039934 - ZHUKOVSKY; Eugene ;   et al. | 2016-02-11 |
Bispecific CD33 and CD3 Binding Proteins App 20160002333 - ELLWANGER; Kristina ;   et al. | 2016-01-07 |
Bispecific CD33 and CD3 binding proteins Grant 9,212,225 - Ellwanger , et al. December 15, 2 | 2015-12-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.